S&P 500   3,344.01 (+1.38%)
DOW   27,618.60 (+1.64%)
QQQ   274.69 (+1.15%)
AAPL   113.20 (+0.82%)
MSFT   208.50 (+0.33%)
FB   255.48 (+0.26%)
GOOGL   1,455.45 (+1.14%)
AMZN   3,140.09 (+1.45%)
TSLA   420.10 (+3.13%)
NVDA   513.74 (-0.23%)
BABA   275.54 (+1.64%)
CGC   14.07 (-0.71%)
GE   6.27 (+2.62%)
MU   49.53 (+0.79%)
AMD   78.78 (+0.92%)
T   28.34 (+1.07%)
F   6.68 (+2.61%)
ACB   4.82 (-4.55%)
GILD   62.91 (+1.06%)
NFLX   481.65 (-0.25%)
DIS   125.74 (+1.40%)
BAC   24.12 (+2.68%)
BA   163.60 (+4.85%)
S&P 500   3,344.01 (+1.38%)
DOW   27,618.60 (+1.64%)
QQQ   274.69 (+1.15%)
AAPL   113.20 (+0.82%)
MSFT   208.50 (+0.33%)
FB   255.48 (+0.26%)
GOOGL   1,455.45 (+1.14%)
AMZN   3,140.09 (+1.45%)
TSLA   420.10 (+3.13%)
NVDA   513.74 (-0.23%)
BABA   275.54 (+1.64%)
CGC   14.07 (-0.71%)
GE   6.27 (+2.62%)
MU   49.53 (+0.79%)
AMD   78.78 (+0.92%)
T   28.34 (+1.07%)
F   6.68 (+2.61%)
ACB   4.82 (-4.55%)
GILD   62.91 (+1.06%)
NFLX   481.65 (-0.25%)
DIS   125.74 (+1.40%)
BAC   24.12 (+2.68%)
BA   163.60 (+4.85%)
S&P 500   3,344.01 (+1.38%)
DOW   27,618.60 (+1.64%)
QQQ   274.69 (+1.15%)
AAPL   113.20 (+0.82%)
MSFT   208.50 (+0.33%)
FB   255.48 (+0.26%)
GOOGL   1,455.45 (+1.14%)
AMZN   3,140.09 (+1.45%)
TSLA   420.10 (+3.13%)
NVDA   513.74 (-0.23%)
BABA   275.54 (+1.64%)
CGC   14.07 (-0.71%)
GE   6.27 (+2.62%)
MU   49.53 (+0.79%)
AMD   78.78 (+0.92%)
T   28.34 (+1.07%)
F   6.68 (+2.61%)
ACB   4.82 (-4.55%)
GILD   62.91 (+1.06%)
NFLX   481.65 (-0.25%)
DIS   125.74 (+1.40%)
BAC   24.12 (+2.68%)
BA   163.60 (+4.85%)
S&P 500   3,344.01 (+1.38%)
DOW   27,618.60 (+1.64%)
QQQ   274.69 (+1.15%)
AAPL   113.20 (+0.82%)
MSFT   208.50 (+0.33%)
FB   255.48 (+0.26%)
GOOGL   1,455.45 (+1.14%)
AMZN   3,140.09 (+1.45%)
TSLA   420.10 (+3.13%)
NVDA   513.74 (-0.23%)
BABA   275.54 (+1.64%)
CGC   14.07 (-0.71%)
GE   6.27 (+2.62%)
MU   49.53 (+0.79%)
AMD   78.78 (+0.92%)
T   28.34 (+1.07%)
F   6.68 (+2.61%)
ACB   4.82 (-4.55%)
GILD   62.91 (+1.06%)
NFLX   481.65 (-0.25%)
DIS   125.74 (+1.40%)
BAC   24.12 (+2.68%)
BA   163.60 (+4.85%)
Log in
OTCMKTS:NVTRQ

Nuvectra Stock Forecast, Price & News

$0.02
-0.01 (-25.00 %)
(As of 06/2/2020)
Add
Compare
Today's Range
$0.02
Now: $0.02
$0.02
50-Day Range
$0.02
MA: $0.02
$0.02
52-Week Range
$0.01
Now: $0.02
$4.30
Volume382,600 shs
Average Volume188,742 shs
Market Capitalization$268,995.00
P/E RatioN/A
Dividend YieldN/A
Beta1.89
Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. The company offers Algovita, a spinal cord stimulation system for the treatment of chronic intractable pain of the trunk and limbs. It is also developing Virtis, a sacral neuromodulation (SNM) system for the treatment of chronic urinary retention and overactive bladder; and technologies to support other indications, including SNM for the treatment of overactive bladder and deep brain stimulation to treat Parkinson's disease. The company serves hospitals, surgery centers, and medical facilities through a direct sales force and third-party distributors in the United States and Europe. Nuvectra Corporation was founded in 2008 and is headquartered in Plano, Texas.
Read More
Nuvectra logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.63 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NVTRQ
Previous SymbolNASDAQ:NVTRV
CUSIPN/A
Phone214-474-3103

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$48.83 million
Book Value$5.28 per share

Profitability

Miscellaneous

Employees197
Market Cap$268,995.00
Next Earnings Date9/30/2020 (Estimated)
OptionableOptionable
$0.02
-0.01 (-25.00 %)
(As of 06/2/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive NVTRQ News and Ratings via Email

Sign-up to receive the latest news and ratings for NVTRQ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Nuvectra (OTCMKTS:NVTRQ) Frequently Asked Questions

How has Nuvectra's stock been impacted by Coronavirus?

Nuvectra's stock was trading at $0.13 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NVTRQ shares have decreased by 88.5% and is now trading at $0.0150.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Nuvectra?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nuvectra in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Nuvectra
.

When is Nuvectra's next earnings date?

Nuvectra is scheduled to release its next quarterly earnings announcement on Wednesday, September 30th 2020.
View our earnings forecast for Nuvectra
.

How were Nuvectra's earnings last quarter?

Nuvectra Corp (OTCMKTS:NVTRQ) posted its earnings results on Monday, October, 29th. The company reported ($0.87) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.86) by $0.01. The company earned $14.22 million during the quarter, compared to analyst estimates of $12.38 million.
View Nuvectra's earnings history
.

Who are some of Nuvectra's key competitors?

Who are Nuvectra's key executives?

Nuvectra's management team includes the following people:
  • Dr. Fred B. Parks Ph.D., CEO & Director (Age 72)
  • Mr. Joseph Paul Hanchin, Pres (Age 57)
  • Mr. Walter Z. Berger, COO, CFO & Exec. VP (Age 63)
  • Ms. Jennifer J. Kosharek, VP, Controller & Principal Accounting Officer (Age 38)
  • Mr. Benjamin Tranchina, Chief Technology Officer

What is Nuvectra's stock symbol?

Nuvectra trades on the OTCMKTS under the ticker symbol "NVTRQ."

How do I buy shares of Nuvectra?

Shares of NVTRQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nuvectra's stock price today?

One share of NVTRQ stock can currently be purchased for approximately $0.02.

How big of a company is Nuvectra?

Nuvectra has a market capitalization of $268,995.00 and generates $48.83 million in revenue each year. Nuvectra employs 197 workers across the globe.

What is Nuvectra's official website?

The official website for Nuvectra is www.nuvectramed.com.

How can I contact Nuvectra?

Nuvectra's mailing address is 5830 GRANITE PKWY SUITE 1100, PLANO TX, 75024. The company can be reached via phone at 214-474-3103 or via email at [email protected]

This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.